Search
CM4620
go.drugbank.com/drugs/DB16466InvestigationalCM4620 (Zegocractin), is under investigation in multiple clinical trials, including NCT04195347 (pancreatitis due to asparaginase), NCT03709342 (PK/PD study in acute pancreatitis), NCT03401190 and NCT04681066 (pancreatitis and SIRS), and...
Wortmannin
go.drugbank.com/drugs/DB08059ExperimentalThis drug acts as a nonspecific, covalent inhibitor of phosphoinositide 3-kinase enzymes (PI3Ks).
Buntanetap
go.drugbank.com/drugs/DB15317InvestigationalBuntanetap (previously known as Posiphen) is under investigation in clinical trial NCT02925650 (Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease).
D-1,4-dithiothreitol
go.drugbank.com/drugs/DB02184ExperimentalA reagent commonly used in biochemical studies as a protective agent to prevent the oxidation of SH (thiol) groups and for reducing disulphides to dithiols. [PubChem]
Platinum
go.drugbank.com/drugs/DB12257InvestigationalPlatinum has been investigated for the treatment and supportive care of Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Primary Cancer, Non Small Cell Lung Cancer, and Primary Peritoneal Carcinoma, among
Monlunabant
go.drugbank.com/drugs/DB21537InvestigationalMonlunabant has a monoisotopic molecular weight of 590.11 Da.
Tizaterkib
go.drugbank.com/drugs/DB21296InvestigationalTizaterkib has a monoisotopic molecular weight of 494.2 Da.
Mizacorat
go.drugbank.com/drugs/DB21458InvestigationalMizacorat has a monoisotopic molecular weight of 494.21 Da.
Zastaprazan
go.drugbank.com/drugs/DB21524InvestigationalZastaprazan has a monoisotopic molecular weight of 362.21 Da.
Linaprazan
go.drugbank.com/drugs/DB20602InvestigationalLinaprazan has a monoisotopic molecular weight of 366.21 Da.